Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism

Abstract Integration of the omics data, including metabolomics and proteomics, provides a unique opportunity to search for new associations within metabolic disorders, including Alzheimer’s disease. Using metabolomics, we have previously profiled oxylipins, endocannabinoids, bile acids, and steroids...

Full description

Bibliographic Details
Main Authors: Kamil Borkowski, Nicholas T. Seyfried, Matthias Arnold, James J. Lah, Allan I. Levey, Chadwick M. Hales, Eric B. Dammer, Colette Blach, Gregory Louie, Rima Kaddurah-Daouk, John W. Newman
Format: Article
Language:English
Published: Nature Portfolio 2023-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-39737-8
_version_ 1797577054110089216
author Kamil Borkowski
Nicholas T. Seyfried
Matthias Arnold
James J. Lah
Allan I. Levey
Chadwick M. Hales
Eric B. Dammer
Colette Blach
Gregory Louie
Rima Kaddurah-Daouk
John W. Newman
author_facet Kamil Borkowski
Nicholas T. Seyfried
Matthias Arnold
James J. Lah
Allan I. Levey
Chadwick M. Hales
Eric B. Dammer
Colette Blach
Gregory Louie
Rima Kaddurah-Daouk
John W. Newman
author_sort Kamil Borkowski
collection DOAJ
description Abstract Integration of the omics data, including metabolomics and proteomics, provides a unique opportunity to search for new associations within metabolic disorders, including Alzheimer’s disease. Using metabolomics, we have previously profiled oxylipins, endocannabinoids, bile acids, and steroids in 293 CSF and 202 matched plasma samples from AD cases and healthy controls and identified both central and peripheral markers of AD pathology within inflammation-regulating cytochrome p450/soluble epoxide hydrolase pathway. Additionally, using proteomics, we have identified five cerebrospinal fluid protein panels, involved in the regulation of energy metabolism, vasculature, myelin/oligodendrocyte, glia/inflammation, and synapses/neurons, affected in AD, and reflective of AD-related changes in the brain. In the current manuscript, using metabolomics-proteomics data integration, we describe new associations between peripheral and central lipid mediators, with the above-described CSF protein panels. Particularly strong associations were observed between cytochrome p450/soluble epoxide hydrolase metabolites, bile acids, and proteins involved in glycolysis, blood coagulation, and vascular inflammation and the regulators of extracellular matrix. Those metabolic associations were not observed at the gene-co-expression level in the central nervous system. In summary, this manuscript provides new information regarding Alzheimer’s disease, linking both central and peripheral metabolism, and illustrates the necessity for the “omics” data integration to uncover associations beyond gene co-expression.
first_indexed 2024-03-10T22:02:29Z
format Article
id doaj.art-8bf68a11806b4e5a948a71379d7cd203
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-10T22:02:29Z
publishDate 2023-08-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-8bf68a11806b4e5a948a71379d7cd2032023-11-19T12:54:13ZengNature PortfolioScientific Reports2045-23222023-08-0113111310.1038/s41598-023-39737-8Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolismKamil Borkowski0Nicholas T. Seyfried1Matthias Arnold2James J. Lah3Allan I. Levey4Chadwick M. Hales5Eric B. Dammer6Colette Blach7Gregory Louie8Rima Kaddurah-Daouk9John W. Newman10West Coast Metabolomics Center, Genome Center, University of California DavisDepartment of Biochemistry, Emory University School of MedicineInstitute of Computational Biology, Helmholtz Zentrum München-German Research Center for Environmental HealthDepartment of Neurology, Emory UniversityDepartment of Neurology, Emory UniversityDepartment of Neurology, Emory UniversityDepartment of Biochemistry, Emory University School of MedicineDuke Molecular Physiology Institute, Duke UniversityDepartment of Psychiatry and Behavioral Sciences, Duke UniversityDepartment of Psychiatry and Behavioral Sciences, Duke UniversityWest Coast Metabolomics Center, Genome Center, University of California DavisAbstract Integration of the omics data, including metabolomics and proteomics, provides a unique opportunity to search for new associations within metabolic disorders, including Alzheimer’s disease. Using metabolomics, we have previously profiled oxylipins, endocannabinoids, bile acids, and steroids in 293 CSF and 202 matched plasma samples from AD cases and healthy controls and identified both central and peripheral markers of AD pathology within inflammation-regulating cytochrome p450/soluble epoxide hydrolase pathway. Additionally, using proteomics, we have identified five cerebrospinal fluid protein panels, involved in the regulation of energy metabolism, vasculature, myelin/oligodendrocyte, glia/inflammation, and synapses/neurons, affected in AD, and reflective of AD-related changes in the brain. In the current manuscript, using metabolomics-proteomics data integration, we describe new associations between peripheral and central lipid mediators, with the above-described CSF protein panels. Particularly strong associations were observed between cytochrome p450/soluble epoxide hydrolase metabolites, bile acids, and proteins involved in glycolysis, blood coagulation, and vascular inflammation and the regulators of extracellular matrix. Those metabolic associations were not observed at the gene-co-expression level in the central nervous system. In summary, this manuscript provides new information regarding Alzheimer’s disease, linking both central and peripheral metabolism, and illustrates the necessity for the “omics” data integration to uncover associations beyond gene co-expression.https://doi.org/10.1038/s41598-023-39737-8
spellingShingle Kamil Borkowski
Nicholas T. Seyfried
Matthias Arnold
James J. Lah
Allan I. Levey
Chadwick M. Hales
Eric B. Dammer
Colette Blach
Gregory Louie
Rima Kaddurah-Daouk
John W. Newman
Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism
Scientific Reports
title Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism
title_full Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism
title_fullStr Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism
title_full_unstemmed Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism
title_short Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism
title_sort integration of plasma and csf metabolomics with csf proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism
url https://doi.org/10.1038/s41598-023-39737-8
work_keys_str_mv AT kamilborkowski integrationofplasmaandcsfmetabolomicswithcsfproteomicrevealsnovelassociationsbetweenlipidmediatorsandcentralnervoussystemvascularandenergymetabolism
AT nicholastseyfried integrationofplasmaandcsfmetabolomicswithcsfproteomicrevealsnovelassociationsbetweenlipidmediatorsandcentralnervoussystemvascularandenergymetabolism
AT matthiasarnold integrationofplasmaandcsfmetabolomicswithcsfproteomicrevealsnovelassociationsbetweenlipidmediatorsandcentralnervoussystemvascularandenergymetabolism
AT jamesjlah integrationofplasmaandcsfmetabolomicswithcsfproteomicrevealsnovelassociationsbetweenlipidmediatorsandcentralnervoussystemvascularandenergymetabolism
AT allanilevey integrationofplasmaandcsfmetabolomicswithcsfproteomicrevealsnovelassociationsbetweenlipidmediatorsandcentralnervoussystemvascularandenergymetabolism
AT chadwickmhales integrationofplasmaandcsfmetabolomicswithcsfproteomicrevealsnovelassociationsbetweenlipidmediatorsandcentralnervoussystemvascularandenergymetabolism
AT ericbdammer integrationofplasmaandcsfmetabolomicswithcsfproteomicrevealsnovelassociationsbetweenlipidmediatorsandcentralnervoussystemvascularandenergymetabolism
AT coletteblach integrationofplasmaandcsfmetabolomicswithcsfproteomicrevealsnovelassociationsbetweenlipidmediatorsandcentralnervoussystemvascularandenergymetabolism
AT gregorylouie integrationofplasmaandcsfmetabolomicswithcsfproteomicrevealsnovelassociationsbetweenlipidmediatorsandcentralnervoussystemvascularandenergymetabolism
AT rimakaddurahdaouk integrationofplasmaandcsfmetabolomicswithcsfproteomicrevealsnovelassociationsbetweenlipidmediatorsandcentralnervoussystemvascularandenergymetabolism
AT johnwnewman integrationofplasmaandcsfmetabolomicswithcsfproteomicrevealsnovelassociationsbetweenlipidmediatorsandcentralnervoussystemvascularandenergymetabolism